Genesis Healthcare Inc. (NYSE:GEN) shares were down 2.7% on Monday . The company traded as low as $2.90 and last traded at $2.92, with a volume of 187,834 shares. The stock had previously closed at $3.00.

Separately, Bank of America Corp. set a $1.80 target price on Genesis Healthcare and gave the stock a “sell” rating in a report on Monday. One investment analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $3.33.

The stock’s market cap is $243.88 million. The company’s 50-day moving average price is $2.37 and its 200 day moving average price is $2.18.

Genesis Healthcare (NYSE:GEN) last announced its quarterly earnings data on Thursday, August 4th. The company reported ($0.26) EPS for the quarter, missing the Zacks’ consensus estimate of $0.01 by $0.27. Genesis Healthcare had a negative net margin of 6.25% and a negative return on equity of 5.36%. The firm earned $1.44 billion during the quarter, compared to analyst estimates of $1.40 billion. During the same period last year, the business posted $0.14 EPS. The company’s revenue was up 1.3% on a year-over-year basis. On average, equities research analysts predict that Genesis Healthcare Inc. will post ($1.49) earnings per share for the current year.

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Alliancebernstein L.P. raised its position in Genesis Healthcare by 5.8% in the second quarter. Alliancebernstein L.P. now owns 77,126 shares of the company’s stock worth $137,000 after buying an additional 4,200 shares in the last quarter. BlackRock Investment Management LLC raised its position in Genesis Healthcare by 10.7% in the second quarter. BlackRock Investment Management LLC now owns 154,153 shares of the company’s stock worth $273,000 after buying an additional 14,865 shares in the last quarter. Geode Capital Management LLC raised its position in Genesis Healthcare by 1.9% in the first quarter. Geode Capital Management LLC now owns 171,157 shares of the company’s stock worth $397,000 after buying an additional 3,206 shares in the last quarter. Bank of New York Mellon Corp raised its position in Genesis Healthcare by 17.5% in the second quarter. Bank of New York Mellon Corp now owns 179,071 shares of the company’s stock worth $317,000 after buying an additional 26,629 shares in the last quarter. Finally, Panagora Asset Management Inc. raised its position in Genesis Healthcare by 4.4% in the first quarter. Panagora Asset Management Inc. now owns 236,320 shares of the company’s stock worth $548,000 after buying an additional 9,936 shares in the last quarter. Institutional investors own 8.07% of the company’s stock.

Genesis Healthcare Company Profile

Genesis Healthcare, Inc, formerly Skilled Healthcare Group, Inc, is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services, including physician services and other healthcare related services.

5 Day Chart for NYSE:GEN

Receive News & Ratings for Genesis Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.